Pharma's reputation may have improved during the pandemic, but that also meant that diversity, equity, and inclusion (DEI) issues were given more attention. Pharma companies have mostly concentrated on equality in recent years, but this new era of health equity is needed to address the expanding population's DEI challenges. To get a report in detail, contact us at - info@insights10.com

1. 10 Healthcare
Players aiming
Beyond Health
Equality to Conquer
Health Equity
A market research report on

2. 2
1. Health Equity: A Virtuous Cycle
2. Factors Manifesting Health Equity
3. Healthcare Players Aiming Healthcare Equity
• Bayer
• Gilead
• Sanofi
• Bristol Myers Squibb
• Johnson & Johnson
• Merck
• Pfizer
• AstraZeneca
• Takeda
• Biogen
What would this Report Cover?

3. 3
Pharmaceutical and life sciences companies has unlocked new opportunities, help underserved patients, and
build a cycle of trust to drive a virtuous cycle
1. Health Equity: A Virtuous Cycle
Health
Equity
1.
Analyse
2.
Expand
3.
Challenge
4.
Engage
1. Analyse (High Quality Data)
Consider the information and data we have now
2. Expand (Problem Solving)
Consider whose problems we have been solving
3. Challenge (Targeted Approaches)
Consider why some groups are not receiving the appropriate medicine or
therapy at the right time
4. Engage (Better Collaboration)
Consider whom else we can collaborate with to fill the identified gaps, & how
we can encourage more people to receive needed care

4. 4
2. Factors Manifesting Health Equity
Intricately complicated health disorders can progress, and access disparities, unmet needs, or marginalized
communities can all be signs of health inequities
Health
Equity
Unmet Needs
Lack of adequate alignment between innovation initiatives and the global burden of
disease
Limited Access
Patients who are unable to access or afford needs like wholesome food, suitable
treatment, or essential medications
Underserved
Communities
Determinants of ecological health (including payers and providers) failing to engage
groups appropriately for the needs of group members

5. 5
3. Healthcare Players Aiming Healthcare Equity (1/5)
▪ Bayer’s U.S. business nabbed a perfect score from the
Human Rights Campaign Foundation’s Corporate
Equality Index
▪ Helps boost the overall ranking from alva for the
company, which also has a major focus on food and
nutrition and agriculture
▪ Bayer also works with the new Women in STEM
leadership pilot program across 12 countries that the
Pistoia Alliance recently announced
Bayer Gilead
▪ Gilead repurposing Ebola drug remdesivir as the first
treatment for COVID boosted its overall reputation last
year
▪ Gilead launched Zeroing In: Ending the HIV Epidemic,
which gifted $24 million in grants to 116 organizations
in 41 countries to tackle the problem on the ground
▪ The company wants to hire or promote 200 Black
Americans without a four-year degree while also
increasing Hispanic representation to 15% of its U.S.
workforce and 3.7% of leadership roles and boosting
female leadership representation to 39%

6. 6
3. Healthcare Players Aiming Healthcare Equity (2/5)
▪ The Paris-based company has launched an Employee
Resource Group (ERG) framework in which voluntary,
employee-led ERGs will focus on five areas—gender,
generations, pride, ability and culture and origins
▪ Sanofi’s DE&I strategy 2025 goals revolve around
three key pillars: building representative leadership,
creating a work environment where employees can
bring their whole selves and engaging with the
company’s diverse communities
Sanofi Bristol Myers Squibb
▪ BMS has been at the forefront of the fight to boost
diversity by issuing $7.9Mn of health equity grants to
24 U.S. nonprofit organizations aimed at improving
access and quality care to medically underserved
patients and communities
▪ BMS until 2025 will accelerate five diversity and
inclusion and health equity commitments—addressing
disparities in healthcare, increasing diversity in clinical
trials, expanding supplier diversity, enhancing
employee giving to social justice organizations and
increasing workforce representation

7. 7
3. Healthcare Players Aiming Healthcare Equity (3/5)
▪ 2022 was Year 1 of the pharma’s Health for Humanity
2025 plan
▪ The program comes with 20 key goals like boosting
women in management, greater diversity in senior
teams and improving health equity by developing
treatments for underserved HIV and tuberculosis
patient communities
▪ By 2025, the pharma has pledged to have 50% of
management positions globally made up of women
and also 35% ethnic/racial diversity in U.S.
management positions
Johnson & Johnson Merck
▪ To boost diversity in its clinical trials, Merck is working
to build new partnerships with organizations like Black
Health Matters, the National Urban League and the
Lazarex Cancer Foundation
▪ The company granted voluntary licenses to several
Indian generic manufacturers in an effort to boost the
availability of molnupiravir in India and in other low-
and middle-income countries
▪ Also teamed up with Johnson & Johnson to scale up
production of J&J's single-shot COVID vaccine to help
expand global access

8. 8
3. Healthcare Players Aiming Healthcare Equity (4/5)
▪ Pfizer recently teamed up with trial site network
Headlands Research to break ground on several new
research sites in diversely populated areas. A new
Headlands facility is set to take root in Brownsville,
Texas—a city of about 180,000 on the border of
Mexico
▪ Pfizer has joined the Paradigm for Parity coalition,
aiming to achieve “full gender parity” by 2030, with a
near-term goal of women holding at least 30% of
senior roles
Pfizer AstraZeneca
▪ The Anglo-Swedish Big Pharma's strategy includes
two 2025 goals: to reach gender equality in
management positions and to launch supplier diversity
programs in 10 new countries outside the US
▪ AstraZeneca also participates in the Pistoia Alliance’s
new Women in STEM leadership pilot program to
enable leadership and mentoring skill development
while furthering workplace diversity

9. 9
3. Healthcare Players Aiming Healthcare Equity (4/5)
▪ Takeda launched the Center for Health Equity and
Patient Affairs (HEPA) as a center of excellence in
2021 and hopes to make it a leader in health equity
and patient centricity to “create a more inclusive
ecosystem and strengthen trust and reputation with
patients and other key external stakeholders around
the world
▪ Takeda is also looking to roll out an enterprise-wide
Candidate Relationship Management tool connected
with an Applicant Tracking System that it hopes will
“create inclusive talent communities”
Takeda Biogen
▪ Biogen created a new four-point plan to focus on
building a more diverse workforce “at all levels” as well
as “building awareness, capability and a sustained
urgency to act”

10. Who should buy this report?
MedTech
Players
HealthTech
Companies
Digital Health
Entities
Pharmaceutical
Players
Other Lifesciences
Companies

11. Cost of this report:
$2,500
Annual Subscription:
$125,000 $60,000
(Includes a total of 50 reports)
www.insights10.com
Will the Expiry of Humira Market Exclusivity and Entry of its
Biosimilars Move the Needle in BioPharma Market?
Metaverse: Paving the way for Health 4.0
Topics of Upcoming Reports
Patient Engagement- a New Standpoint on Care that is
Patient-Centered
E-Rx, the Digital Version of Prescription Improvising the
Chances of Better Patient Outcomes
Integration of Healthcare Systems with Big Data and Data
Silos

12. Methodology & Scope

13. 13 A Sample Report on Singapore Physiotherapy Market Analysis I Confidential
Research Methodology
▪ Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the
key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive
overview of the competitive landscape to help our clients make informed strategic decisions
▪ We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial
phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government
and regulatory published material, technical journals, trade magazines, and paid data sources
▪ For forecasting, the following parameters are considered:
❑ Market drivers and restraints along with their current and expected impacts
❑ Technological scenario and expected developments
❑ End use industry trends and dynamics
❑ Trends in the consumer behavior
❑ Regulatory scenario and expected developments
❑ Current capacity and expected capacity additions up to 2030
▪ We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected
market growth rate
▪ We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-
sensitive, reflecting the most recent value and volume of the market across regions
▪ All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪ Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)

14. 14 A Sample Report on Singapore Physiotherapy Market Analysis I Confidential
Analysis Methodology
Our Analysis Methodology involves three critical stages:
Primary
Research
Secondary
Research
Market Trends
Market Sizing &
Analysis
Data Triangulation &
Validation
Analysis &
Interpretation
Insights
Presentation &
Reporting
Data Collection
Market Data Analysis
& Statistical Model
Interpretation &
Presentation

15. 15 A Sample Report on Singapore Physiotherapy Market Analysis I Confidential
Data Triangulation & Data Validation
Bottom Up Approach
Summarization of revenue
generated from companies
to arrive at total market size
Revenue generated by products &
services offered by companies
Validation from
Primary Interview
Final
Market
Size
Top Down Approach
Final Market size break up to
rest of segmentation
Arriving at market size
of each segment
Validation from
Primary Interview
Final
Summary

16. 16 A Sample Report on Singapore Physiotherapy Market Analysis I Confidential
Key Benefits for Stakeholders from this Report
Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent
investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and
quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided
Comprehensive quantitative analysis of the industry from 2021 to 2030F is provided to enable the stakeholders to capitalize on
the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally
Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater
understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors

17. 2021
2022-
2030
Report Attribute
Quantitative Units
Report Coverage
Customized Report
Pricing and purchase
options
Revenue in USD Million/Billion (Mn/Bn)
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (5 working days) with
purchase. We will provide you with data that is
currently not a part of our scope as a part of
customization
Avail customized purchase options to meet
your exact research needs
Details
Time Frame
Base Year for
Estimation
Forecast
Period

18. The report is prepared
using a proven
methodology and
insightful research
Reliable
The data is prepared by
a team of highly qualified
& experienced research
analysts & vetted by our
local associates
Expert-verified
Allowing you to
confidently make
smarter business
and strategic
decisions
Real
Covers everything you
would need to know
about the market
including market size,
competitive analysis &
much more
Comprehensive
You do not have to be a
market expert to
understand what really is
happening on the market
and how it works
Easy to read
What kind of Data is Presented
in this Report?
This report presents data, which is:
www.insights10.com

19. About

20. www.insights10.com
A large database of over 30,000 syndicated market
research reports in pharmaceuticals and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Lifesciences Market
Research Reports you
can trust

21. Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get Insights to take
informed Business
Decisions
www.insights10.com

22. Market Research Reports
across various domains of healthcare
Healthcare
Services
Clinical
Trials
OTC &
Nutraceuticals
Pharmaceuticals
(Diseases & Drugs)
Digital
Health
Medical
Devices

23. Our
Services
1
2
3
4
5
6
10
9
8
7
Market Research Reports
Customized Reports
Primary Research
Database Services
Full-Time Engagement
Conference Coverage
Competitive Intelligence
Strategic Research Projects Regulatory Compliance
Report Subscription Services

24. Our Research Process
01 03
02 04 05
Identification of
Data
Collection of
Data
Market
Dynamics
Collaboration
of Data
Verification &
Analysis
www.insights10.com

25. Statistical Databases
Data
Sources
We have access to multiple highly
reliable free and subscription data
sources. We have many years of
experience to understand which
sources are more dependable for what
and which to prefer for the reliable and
latest information.
Company Websites/Annual Reports
Trade Publications
Online Databases
Published Research Reports
Whitepapers
Press Releases of Key Market Players
www.insights10.com

26. Research Projects Done
Over the years, we have developed an in-depth experience of executing
market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Africa and
Asia Pacific regions

27. Mukesh is an engineering graduate
with an MBA in Marketing. He is a
seasoned healthcare market
research & marketing professional
with a progressive experience of over
20 years in Life Sciences, Pharma
and Medical Device sectors . With an
in-depth understanding of primary
research, he has conducted
hundreds of interviews of various
stakeholders in pharma & healthcare
& completed several research
projects across life sciences industry.
Ritu has over 6 years of experience in
strategy building, market assessments,
market sizing, and RWE for global MNC
healthcare & biopharma clients across
diff. markets (America, Europe, Africa,
APAC and Middle East). Her areas of
expertise include: Indentifying emerging
trends in life sciences industry,
Competitor landscape assessment,
Disease opportunity assessments etc.
She is a pro in secondary and primary
research with a deep domain expertise
in healthcare sector.
Purav is a physician and an
entrepreneur with 12+ years of
experience in Healthcare & Life
Sciences industry spanning across
strategy, market access, health
informatics and RWE, Digital
Healthcare, analytics and data science.
Purav studied medicine from Gujarat
University and also completed his MBA
from IIM-Kozhikode. Purav started his
career with Deloitte working on strategy
consulting engagements and also co-
founded ConvergeHealth by Deloitte.
Dhruv Joshi is an engineer and has done
Masters in Hospital Administration with
over 4 years of experience in the
healthcare and life science industry. He
has gained proficiency in market
research, market assessment, and
developing insights from it. He has
worked on various consulting projects
across different geographies including
Asia, Europe, US, MENA. He has been
aligned in working for sector reports of
various geographies along with market
sizing and forecasting.
Dr. Purav Gandhi
Founder & CEO
Mukesh Nayak
Head - Marketing
Ritu Baliya
Engagement Manager
Dhruv Joshi
Consultant
Project Leadership Team

28. 7 years of experience working with leading organizations in pharma, MedTech
and healthcare domain. Some of our recent clients are mentioned below
… and many more

29. Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
Whatsapp: (+91) 931 639 7935
We would be happy to help.